'Convenient' new drug to treat stroke?

Posted on 11 August 2011

A new drug could help patients with an irregular heartbeat, making it easier for those with long term care plans to be treated.

Research led by the University of Edinburgh and Duke University compared warfarin, the standard treatment for this condition, with rivaroxaban.

The new drug was seen to be just as effective as warfarin at reducing the risk of stroke, and is much easier to administer.

While the impact of warfarin needs to be measured and dosage possibly adjusted, rivaroxaban does not need to be so closely monitored.

Professor Keith Fox, of the University of Edinburgh, said: "We know that about a third of patients eligible for warfarin are not currently receiving it. This may be because they are too frail and may not be able to manage taking the drug appropriately, with the need for blood tests and dosage levels to be monitored closely."

In other news, the risk of experiencing a stroke rises tenfold in the first three months following a traumatic brain injury, according to research published in journal Stroke.

Posted by Natalie Edwards



News search form